Search

Koteswara Chintalacharuvu Phones & Addresses

  • San Pedro, CA
  • Celina, TX
  • Naples, FL
  • Los Angeles, CA
  • Huntington Beach, CA
  • Torrance, CA
  • Inglewood, CA
  • Saint Louis, MO
  • Cleveland, OH

Work

Company: Toyota Dec 2015 to Apr 2017 Position: Consultant

Education

Degree: Doctorates, Doctor of Philosophy Specialities: Philosophy

Skills

Laboratory • Data Science • Cell Biology • Personnel Management • Elisa • Data Center • Western Blotting • In Vivo • Antibodies • Data Analysis • Predictive Analytics • Biotechnology • Pcr • Immunology • Project Finance • Life Sciences • Cell Culture • Strategic Planning • Molecular Biology • Lifesciences • Lab Management • Big Data • Quantitative Analytics • In Vitro • Protein Expression • Research • Biochemistry • Science • Intellectual Property • Grant Writing and Administration • Analytics • Statistics • Data Mining • Big Data Analytics • Database Administration • Databases

Languages

English • Telugu

Ranks

Certificate: Coursera Verified Certificates, License Fphlet7Am4

Interests

Boating • Aerobics • Cooking • Exercise • Outdoors • Home Improvement • Reading • Fitness • Sports • Home Decoration

Industries

Hospital & Health Care

Resumes

Resumes

Koteswara Chintalacharuvu Photo 1

Founder | Director Data Science Analytics

View page
Location:
5312 Jacques St, Torrance, CA 90503
Industry:
Hospital & Health Care
Work:
Toyota Dec 2015 - Apr 2017
Consultant

Krctek Dec 2015 - Apr 2017
Senior Data Scientist | Analytics

Toyota Dec 2015 - Oct 2016
Data Scientist

Data Science Analytics Leadership Greater Los Angeles Area Dec 2015 - Oct 2016
Founder | Director Data Science Analytics

Viewics, Inc. Jul 2015 - Nov 2015
Director | Data Science, Analytics, Biotechology
Education:
Calcutta University, Kolkata 1979 - 1982
Bachelors, Bachelor of Science, Organic Chemistry
Skills:
Laboratory
Data Science
Cell Biology
Personnel Management
Elisa
Data Center
Western Blotting
In Vivo
Antibodies
Data Analysis
Predictive Analytics
Biotechnology
Pcr
Immunology
Project Finance
Life Sciences
Cell Culture
Strategic Planning
Molecular Biology
Lifesciences
Lab Management
Big Data
Quantitative Analytics
In Vitro
Protein Expression
Research
Biochemistry
Science
Intellectual Property
Grant Writing and Administration
Analytics
Statistics
Data Mining
Big Data Analytics
Database Administration
Databases
Interests:
Boating
Aerobics
Cooking
Exercise
Outdoors
Home Improvement
Reading
Fitness
Sports
Home Decoration
Languages:
English
Telugu
Certifications:
Coursera Verified Certificates, License Fphlet7Am4
The Data Scientist’s Toolbox
License Fphlet7Am4

Publications

Us Patents

Iga Antibody Protein As A Cytotoxic Drug

View page
US Patent:
20060029597, Feb 9, 2006
Filed:
Mar 31, 2005
Appl. No.:
11/094302
Inventors:
Koteswara Chintalacharuvu - Torrance CA, US
Manuel Penichet - Los Angeles CA, US
Sherie Morrison - Los Angeles CA, US
Assignee:
Chimeric Technologies - Los Angeles CA
International Classification:
A61K 39/395
C12N 5/06
C07K 16/44
US Classification:
424133100, 530387300, 435328000
Abstract:
Novel compounds are disclosed. The compounds are useful for inducing apoptosis, cell death and/or inhibiting proliferation of cells. Also disclosed are pharmaceutical compositions and methods associated with the compounds.

Modified Immunoglobin Molecules And Methods For Use Thereof

View page
US Patent:
62845365, Sep 4, 2001
Filed:
Apr 20, 1999
Appl. No.:
9/295283
Inventors:
Sherie L. Morrison - Los Angeles CA
Koteswara R. Chintalacharuvu - Los Angeles CA
Esther Mikyung Yoo - Thousand Oaks CA
Kham M. Trinh - Monterey Park CA
M. Josefina Coloma - Santa Monica CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C12N 506
C12Q 170
G01N 3353
A61K 39395
C12P 2108
US Classification:
435328
Abstract:
Disclosed are modified immunoglobulin (Ig) molecules, a method of producing modified Ig molecules, and methods for treatment and prevention of infectious diseases using modified Ig molecules. In one embodiment, the modified Ig molecule comprises a C. sub. H 3 domain of an IgA molecule (. alpha. C. sub. H 3). The combination of an. alpha. C. sub. H 3 with other domains selected from one or more nonIgA Ig molecules provides an Ig molecule that has the capacity to bind J chain and/or secretory component (SC) together with features of a nonIgA molecule. In another embodiment, the modified Ig molecule comprises a C. sub. H 1 and/or a C. sub. H 2 domain of an IgA molecule. The combination of an. alpha. C. sub. H 1 and/or C. sub. H 2 domain with other domains selected from one or more nonIgA Ig molecules provides an Ig molecule that has the capacity to form higher polymers (trimers, tetramers, pentamers, etc.
Koteswara Rao Chintalacharuvu from San Pedro, CA, age ~72 Get Report